Literature DB >> 29880208

Prevalence of multiple infections and the risk of gastric adenocarcinoma development at earlier age.

Sadegh Fattahi1, Novin Nikbakhsh2, Hassan Taheri3, Elham Ghadami4, Mohadeseh Kosari-Monfared4, Galia Amirbozorgi5, Mohsen Asouri5, Maryam Pilehchian-Langroudi4, Mohammad Ranaee6, Ali Akbar Samadani7, Mahdi Paryan8, Haleh Akhavan-Niaki9.   

Abstract

Helicobacter pylori and Epstein-Barr virus are well established infections for gastric cancer development. However, the role of cytomegalovirus alone or in combination with other infections is unclear. In this case-control study, the prevalence of different infections was evaluated, and their frequency was compared with clinicopathologic features among gastric cancer patients and normal volunteers from 2012 to 2017. Approximately two-thirds (61.9%) of the gastric cancer patients had at least 1 viral infection, while viral infection prevalence in normal volunteers was only 4.7% (P = 0.021). The higher infection frequency in gastric cancer patients was observed for EBV (49.2%). No CMV DNA was detected in normal volunteers. In contrast, one-fourth of the gastric cancer patients were infected with CMV. Furthermore, CMV frequency in tumoral tissues (68.75%) was significantly higher than in nontumoral tissues (12.5%) (P = 0.0311). Although H. pylori infection was significantly lower in tumoral tissues than in nontumoral tissues (P = 0.0136), all tumoral tissues had cagA, while only 61.5% of nontumoral tissues were cagA positive. CMV-infected patients were affected 14 years earlier than uninfected, and CMV-negative patients (mean age = 56 vs. 69 and 70 years; P= 7.6×10-3 and P = 2.7×10-4, respectively). Also, EBV viral load in earlier grades and stages was more than 100-fold higher than advanced grades and stages. Our results show a high level of infections in gastric cancer. The association of these infections especially with CMV contributes to gastric adenocarcinoma development at earlier age.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Age; Co-infection; Cytomegalovirus; Epstein–Barr virus; Gastric cancer

Mesh:

Year:  2018        PMID: 29880208     DOI: 10.1016/j.diagmicrobio.2018.04.015

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  11 in total

Review 1.  Kinases and therapeutics in pathogen mediated gastric cancer.

Authors:  Charu Sonkar; Nidhi Varshney; Siva Koganti; Hem Chandra Jha
Journal:  Mol Biol Rep       Date:  2022-01-15       Impact factor: 2.316

2.  Association between Gastric Pathology and Hepatitis B Virus Infection in Patients with or without Helicobacter Pylori.

Authors:  Mahmoud Baghbanian; Seyyed Abolfazl Hoseini Mousa; Masoud Doosti; Mansour Moghimi
Journal:  Asian Pac J Cancer Prev       Date:  2019-07-01

3.  Efficacy and tolerability of fourteen-day sequential quadruple regimen: pantoprazole, bismuth, amoxicillin, metronidazole and or furazolidone as first-line therapy for eradication of Helicobacter pylori: a randomized, double-blind clinical trial.

Authors:  Fariborz Mansour-Ghanaei; Alireza Samadi; Farahnaz Joukar; Hafez Tirgar Fakheri; Soheil Hassanipour; Mohammad Taghi Ashoobi; Soheil Soltanipour; Ahmad Alizadeh; Gholamreza Rezamand; Mohammad Fathalipour
Journal:  EXCLI J       Date:  2019-08-19       Impact factor: 4.068

Review 4.  Role of Bacterial and Viral Pathogens in Gastric Carcinogenesis.

Authors:  Manikandan Palrasu; Elena Zaika; Wael El-Rifai; Jianwen Que; Alexander I Zaika
Journal:  Cancers (Basel)       Date:  2021-04-14       Impact factor: 6.575

5.  Association of sonic hedgehog signaling pathway genes IHH, BOC, RAB23a and MIR195-5p, MIR509-3-5p, MIR6738-3p with gastric cancer stage.

Authors:  Sadegh Fattahi; Novin Nikbakhsh; Mohammad Ranaei; Davood Sabour; Haleh Akhavan-Niaki
Journal:  Sci Rep       Date:  2021-04-02       Impact factor: 4.379

6.  LINC02688 and PP7080 as novel biomarkers in early diagnosis of gastric cancer.

Authors:  Sadegh Fattahi; Novin Nikbakhsh; Hassan Taheri; Elham Ghadami; Mohammad Ranaee; Haleh Akhavan-Niaki
Journal:  Noncoding RNA Res       Date:  2021-04-21

7.  Associations between hepatitis B virus exposure and the risk of extrahepatic digestive system cancers: A hospital-based, case-control study (SIGES).

Authors:  Hui Wang; Xin-Zu Chen; Xiao-Long Chen; Wei-Han Zhang; Kai Liu; You-Juan Wang; Huai-Rong Tang; Jian-Kun Hu
Journal:  Cancer Med       Date:  2021-05-02       Impact factor: 4.452

8.  Chronic Hepatitis Virus Infection Are Associated With High Risk of Gastric Cancer: A Systematic Review and Cumulative Analysis.

Authors:  Yusha Yang; Zufu Jiang; Weizhou Wu; Libin Ruan; Chengyang Yu; Yuning Xi; Liling Wang; Kunpeng Wang; Jinggang Mo; Shankun Zhao
Journal:  Front Oncol       Date:  2021-07-08       Impact factor: 6.244

9.  Estimating the treatment effect in patients with gastric cancer in the presence of noncompliance.

Authors:  Malihe Safari; Hossein Mahjub; Habib Esmaeili; Sanambar Sadighi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2021

10.  Associations Between Gastric Cancer Risk and Virus Infection Other Than Epstein-Barr Virus: A Systematic Review and Meta-analysis Based on Epidemiological Studies.

Authors:  Hui Wang; Xiao-Long Chen; Kai Liu; Dan Bai; Wei-Han Zhang; Xin-Zu Chen; Jian-Kun Hu
Journal:  Clin Transl Gastroenterol       Date:  2020-07       Impact factor: 4.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.